China · Delayed Price · Currency is CNY Hinova Pharmaceuticals Statistics
Total Valuation
SHA:688302 has a market cap or net worth of CNY 3.51 billion. The enterprise value is 2.89 billion.
| Market Cap | 3.51B |
| Enterprise Value | 2.89B |
Important Dates
The last earnings date was Saturday, October 31, 2026.
| Earnings Date | Oct 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688302 has 99.02 million shares outstanding. The number of shares has decreased by -1.25% in one year.
| Current Share Class | 99.02M |
| Shares Outstanding | 99.02M |
| Shares Change (YoY) | -1.25% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 20.16% |
| Owned by Institutions (%) | 15.13% |
| Float | 71.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 42.37 |
| PB Ratio | 3.64 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 34.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.11.
| Current Ratio | 5.42 |
| Quick Ratio | 5.05 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,320.98 |
Financial Efficiency
Return on equity (ROE) is -13.43% and return on invested capital (ROIC) is -9.56%.
| Return on Equity (ROE) | -13.43% |
| Return on Assets (ROA) | -8.39% |
| Return on Invested Capital (ROIC) | -9.56% |
| Return on Capital Employed (ROCE) | -16.12% |
| Weighted Average Cost of Capital (WACC) | 4.08% |
| Revenue Per Employee | 316,205 |
| Profits Per Employee | -529,124 |
| Employee Count | 262 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0.52 |
Taxes
In the past 12 months, SHA:688302 has paid 3,075 in taxes.
| Income Tax | 3,075 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.37% in the last 52 weeks. The beta is -0.01, so SHA:688302's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -31.37% |
| 50-Day Moving Average | 31.50 |
| 200-Day Moving Average | 38.99 |
| Relative Strength Index (RSI) | 64.61 |
| Average Volume (20 Days) | 2,737,355 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688302 had revenue of CNY 82.85 million and -138.63 million in losses. Loss per share was -1.41.
| Revenue | 82.85M |
| Gross Profit | 79.71M |
| Operating Income | -174.02M |
| Pretax Income | -138.63M |
| Net Income | -138.63M |
| EBITDA | -168.27M |
| EBIT | -174.02M |
| Loss Per Share | -1.41 |
Balance Sheet
The company has 725.86 million in cash and 103.79 million in debt, with a net cash position of 622.07 million or 6.28 per share.
| Cash & Cash Equivalents | 725.86M |
| Total Debt | 103.79M |
| Net Cash | 622.07M |
| Net Cash Per Share | 6.28 |
| Equity (Book Value) | 963.23M |
| Book Value Per Share | 9.79 |
| Working Capital | 659.03M |
Cash Flow
In the last 12 months, operating cash flow was -125.49 million and capital expenditures -48.37 million, giving a free cash flow of -173.86 million.
| Operating Cash Flow | -125.49M |
| Capital Expenditures | -48.37M |
| Depreciation & Amortization | 5.75M |
| Net Borrowing | -3.52M |
| Free Cash Flow | -173.86M |
| FCF Per Share | -1.76 |
Margins
Gross margin is 96.21%, with operating and profit margins of -210.05% and -167.34%.
| Gross Margin | 96.21% |
| Operating Margin | -210.05% |
| Pretax Margin | -167.33% |
| Profit Margin | -167.34% |
| EBITDA Margin | -203.11% |
| EBIT Margin | -210.05% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688302 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.25% |
| Shareholder Yield | 1.25% |
| Earnings Yield | -3.98% |
| FCF Yield | -4.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |